Ovid Therapeutics Inc. — All Filings
493 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
PREM14A
S-1
S-1/A
S-3
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001628280-25-011839 | Mar 11, 2025 | Mar 10, 2025 |
| 10-K | 10-K | 0001628280-25-011844 | Mar 11, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001193125-25-047174 | Mar 5, 2025 | Mar 1, 2025 |
| 4 | — | 0001415889-25-006568 | Mar 4, 2025 | Mar 3, 2025 |
| 3 | — | 0001415889-25-006566 | Mar 4, 2025 | Mar 1, 2025 |
| 4 | — | 0001415889-25-005997 | Feb 28, 2025 | Feb 26, 2025 |
| 4 | — | 0001415889-25-005998 | Feb 28, 2025 | Feb 26, 2025 |
| 4 | — | 0001415889-25-005368 | Feb 24, 2025 | Feb 20, 2025 |
| 4 | — | 0001415889-25-005366 | Feb 24, 2025 | Feb 20, 2025 |
| 4 | — | 0001415889-25-005367 | Feb 24, 2025 | Feb 20, 2025 |
| SCHEDULE 13G/A | — | 0001013594-25-000311 | Feb 14, 2025 | — |
| 8-K | 8-K | 0001193125-25-026192 | Feb 13, 2025 | Feb 10, 2025 |
| 4 | — | 0001415889-25-002230 | Jan 29, 2025 | Jan 27, 2025 |
| 4 | — | 0001415889-24-029474 | Dec 16, 2024 | Dec 12, 2024 |
| 4 | — | 0001415889-24-029472 | Dec 16, 2024 | Dec 12, 2024 |
| 4 | — | 0001415889-24-029471 | Dec 16, 2024 | Dec 12, 2024 |
| 4 | — | 0001415889-24-029473 | Dec 16, 2024 | Dec 12, 2024 |
| SC 13G/A | AMENDMENT NO. 5 TO SCHEDULE 13G | 0000921895-24-002737 | Nov 14, 2024 | — |
| SC 13G/A | — | 0000935836-24-000717 | Nov 14, 2024 | — |
| 8-K | 8-K | 0001628280-24-046867 | Nov 12, 2024 | — |
| 10-Q | 10-Q | 0001628280-24-046868 | Nov 12, 2024 | Sep 30, 2024 |
| 4 | — | 0001415889-24-023237 | Sep 11, 2024 | Sep 9, 2024 |
| 3 | — | 0001415889-24-023235 | Sep 11, 2024 | Sep 9, 2024 |
| 8-K | 8-K | 0001193125-24-217302 | Sep 11, 2024 | Sep 8, 2024 |
| 8-K | 8-K | 0001628280-24-036859 | Aug 13, 2024 | — |
| 10-Q | 10-Q | 0001628280-24-036860 | Aug 13, 2024 | Jun 30, 2024 |
| 8-K | 10-Q | 0001628280-24-034481 | Aug 2, 2024 | Jul 30, 2024 |
| 4 | — | 0001415889-24-020526 | Aug 1, 2024 | Jul 30, 2024 |
| 8-K | 8-K | 0001628280-24-030546 | Jul 1, 2024 | — |
| 8-K | 8-K | 0001193125-24-172225 | Jun 28, 2024 | Jun 27, 2024 |
| 8-K | 8-K | 0000950170-24-073998 | Jun 17, 2024 | — |
| 8-K | 8-K | 0000950170-24-070673 | Jun 7, 2024 | Jun 6, 2024 |
| 8-K | 8-K | 0001628280-24-023064 | May 14, 2024 | — |
| 10-Q | 10-Q | 0001628280-24-023067 | May 14, 2024 | Mar 31, 2024 |
| S-8 | S-8 | 0001193125-24-138390 | May 14, 2024 | — |
| DEF 14A | DEF 14A | 0000950170-24-047673 | Apr 24, 2024 | — |
| DEFA14A | DEFA14A | 0000950170-24-047676 | Apr 24, 2024 | — |
| ARS | ARS | 0000950170-24-047688 | Apr 24, 2024 | — |
| 4 | FORM 4 SUBMISSION | 0001209191-24-005001 | Mar 20, 2024 | Mar 18, 2024 |
| 8-K | 8-K | 0001628280-24-009807 | Mar 8, 2024 | — |
| 10-K | 10-K | 0001628280-24-009809 | Mar 8, 2024 | Dec 31, 2023 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-003958 | Feb 26, 2024 | Feb 22, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-003956 | Feb 26, 2024 | Feb 22, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-003960 | Feb 26, 2024 | Feb 22, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-003962 | Feb 26, 2024 | Feb 22, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-003972 | Feb 26, 2024 | Feb 22, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-003964 | Feb 26, 2024 | Feb 22, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-003966 | Feb 26, 2024 | Feb 22, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-003968 | Feb 26, 2024 | Feb 22, 2024 |
| 4 | FORM 4 SUBMISSION | 0001209191-24-003970 | Feb 26, 2024 | Feb 22, 2024 |